A schematic diagram showing seven distinct molecular subtypes of medulloblastoma, a rare pediatric brain tumor / Courtesy of Kookmin University
A Kookmin University research team has identified previously unrecognized molecular subtypes of medulloblastoma, a rare and aggressive pediatric brain tumor, in collaboration with researchers in Korea and abroad, opening new possibilities for personalized treatment.
The university said Friday that the team, led by applied chemistry professor Kim Kyung-hee, conducted the study as part of the National Cancer Center’s Cancer Proteogenomics Research Program, an initiative dedicated to advancing proteogenomics-based precision medicine for cancer.
The collaborative research team included Kim Young-wook of the National Cancer Center, Park Jong-bae of Kyung Hee University, Kim Seung-ki of Seoul National University, Yoon Jong-hyuck of the Korea Brain Research Institute and Jason K. Sa of Korea University.
International collaborators included Antonio Iavarone and Fulvio D’Angelo from the University of Miami Miller School of Medicine and Michael D. Taylor of the Toronto-based Hospital for Sick Children.
